Disease Overview：Dry eye syndrome（DES）
Dry eye syndrome (keratoconjunctivitis sicca) is a multifactorial disorder of the tear film characterized by insufficient tear production, excessive evaporation, or poor tear quality—leading to ocular surface inflammation, discomfort, visual disturbance, and potential corneal damage. Common symptoms include persistent dryness, grittiness, burning, photophobia, blurred vision, and paradoxical tearing. Etiologies span aging, hormonal changes, autoimmune conditions (e.g., Sjögren’s syndrome), prolonged screen use, contact lens wear, and systemic medications. Diagnosis relies on clinical evaluation alongside objective tests: tear breakup time (TBUT), Schirmer’s test, meibomian gland assessment via meibography, and ocular surface staining (e.g., fluorescein, lissamine green). Management follows a stepwise approach—from artificial tears and lid hygiene to anti-inflammatory agents (cyclosporine A, lifitegrast), punctal plugs, intense pulsed light (IPL) therapy, and advanced interventions like autologous serum eye drops or amniotic membrane transplantation for severe cases.
China offers distinct advantages for dry eye treatment: leading ophthalmology centers—such as Beijing Tongren Hospital and Shanghai Eye & ENT Hospital—combine deep expertise in ocular surface disease with cutting-edge technology, including high-resolution meibography, IPL platforms with customized protocols, and AI-assisted tear film analysis. Clinical outcomes are robust, with published studies reporting >85% symptom improvement in moderate-to-severe cases after integrated IPL–lid debridement regimens. Treatment costs remain 40–60% lower than in the US or Western Europe, without compromising standards—accredited hospitals adhere to ISO 9001 and JCI-aligned quality frameworks. As a dedicated medical tourism agency, we streamline international care: verifying physician credentials, coordinating appointments at top-tier hospitals, providing itemized, transparent pricing in advance, arranging interpreters and post-treatment follow-up, and offering end-to-end support—from visa assistance to recovery accommodation.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Dry Eye Syndrome (Ophthalmology)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Mild-to-moderate symptoms, tear film instability, early meibomian gland dysfunction.
- •Comprehensive Dry Eye Workup (Tear osmolarity, MMP-9 test, meibography, Schirmer I): $48–$62
- •Preservative-free artificial tears (30 mL bottle, 3–6 month supply): $12–$28
- •Topical cyclosporine 0.05% ophthalmic emulsion (30-dose vial, 3-month course): $85–$112
- •Lifitegrast 5% ophthalmic solution (30-dose vial, 3-month course): $142–$178
- •Intense Pulsed Light (IPL) therapy (4-session course, including lid debridement & expression): $320–$410 per course
- •Thermal pulsation (LipiFlow®) (single session, includes pre-op assessment & post-op follow-up): $680–$820
Surgical / Procedural / Interventional Options
*Eligibility criteria:* Severe aqueous-deficient or evaporative dry eye unresponsive to ≥6 months of maximal medical therapy; confirmed meibomian gland atrophy or lacrimal duct obstruction.
- •Punctal plug insertion (silicone, bilateral, with slit-lamp placement & follow-up): $115–$155
- •Autologous serum eye drops (20 mL batch, prepared from patient’s plasma, 1-month supply): $290–$365
- •Meibomian gland probing & expression (under topical anesthesia, bilateral): $220–$285
- •Amniotic membrane transplantation (cryopreserved, sutureless placement for severe corneal epitheliopathy): $1,180–$1,490
Special / Complex Condition Options
- •Sjögren’s-associated dry eye: Rituximab infusion (2 doses, 1,000 mg each, plus monitoring): $2,850–$3,420
- •Post-chemotherapy or graft-versus-host disease dry eye: Topical corticosteroid taper + autologous serum: $410–$530/month
- •Neuropathic dry eye: Oral gabapentin + topical nerve growth factor (Cenegermin 0.005%, 20-dose vial): $1,920–$2,280/course
Quick Selection Guide
- •<45 years, mild symptoms, budget < $200: Start with preservative-free tears + IPL ($320–$410 total); avoid systemic agents.
- •45–65 years, moderate evaporative disease, budget $500–$900: LipiFlow® ($680–$820) + cyclosporine ($85–$112); highest cost-effectiveness ratio.
- •>65 years, severe aqueous deficiency + Sjögren’s: Punctal plugs ($115–$155) + autologous serum ($290–$365/month); prioritize infection prevention.
- •Any age, comorbid rheumatoid arthritis or lupus: Cyclosporine + rituximab only if refractory; baseline cost ~$3,000/course.
- •Post-cataract surgery dry eye (<6 months): Lifitegrast ($142–$178) + thermal expression ($220–$285); avoids procedural delay.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Dry eye syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Dry eye syndrome treatment with China top medical destinations:
